 RedHill Biopharma Significantly Extends Unrestricted Commercial Coverage for Talicia with OptumRx Addition of Talicia by OptumRx significantly extends Commercial patient access to Talicia through this leader in U.S. healthcare Patient access to Talicia now extends to greater than 8 out of 10 covered U.S. Commercial lives Talicia is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. 